Other OTC - Delayed Quote USD

Pharmagreen Biotech Inc. (PHBI)

0.0007 0.0000 (0.00%)
At close: 1:49 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Peter Wojcik B.A. President, CEO, Secretary, Treasurer & Director 93.96k -- 1972
Mr. Terry Kwan B.Com., C.A., CPA CFO & Principal Accounting Officer 93.96k -- 1948

Pharmagreen Biotech Inc.

2987 Blackbear Court
Coquitlam, BC V3E 3A2
Canada
702-803-9404 https://www.pharmagreen.ca
Sector: 
Healthcare

Description

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. Its primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. The company also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

Corporate Governance

Pharmagreen Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers